Terug
37
Dagbereik
€ 41,04
€ 42,06
52-Weeksbereik
€ 34,89
€ 50,88
Volume
4.752.852
50D / 200D Gem.
€ 44,71
/
€ 44,03
Vorige Slotkoers
€ 42,21
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 29,0 | 0,2 |
| P/B | 3,1 | 2,8 |
| ROE % | 8,5 | 3,7 |
| Net Margin % | 4,1 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 1,2 | 0,2 |
Koersdoel Analisten
Hold
€ 48,59
+17.5%
Low: € 38,00
High: € 56,00
Forward K/W
29,07
Forward WPA
€ 1,47
WPA Groei (sch.)
+0,0%
Omzet Sch.
30,86B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,39
€ 2,37 – € 2,41
|
41,06B | 3 |
| FY2029 |
€ 2,12
€ 2,10 – € 2,14
|
38,25B | 3 |
| FY2028 |
€ 1,85
€ 1,75 – € 2,08
|
35,82B | 9 |
No quarterly estimates available
Earnings Surprises
Last 2 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | € 0,24 | -€ 0,01 | -104,2% |
| 2025-11-04 | N/A | € 0,31 | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Generating 1,74B in free cash flow
Cash machine — converts 150,47% of earnings into free cash flow
Capital efficient — spends only 0,00% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)11,47%
Earnings (1Y)-3,42%
FCF Growth (3Y)11,61%
Kwaliteit
Return on Equity
8,50%
ROIC7,12%
Net Margin4,08%
Op. Margin7,78%
Veiligheid
Debt / Equity
1,17
Current Ratio4,29
Interest Coverage0,00
Waardering
P/E Ratio
28,96
Forward P/E29,07
P/B Ratio3,13
EV/EBITDA19,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,47% | Revenue Growth (3Y) | 10,63% |
| Earnings Growth (1Y) | -3,42% | Earnings Growth (3Y) | 122,55% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 28,43B | Net Income (TTM) | 1,16B |
| ROE | 8,50% | ROA | 3,01% |
| Gross Margin | 26,44% | Operating Margin | 7,78% |
| Net Margin | 4,08% | Free Cash Flow (TTM) | 1,74B |
| ROIC | 7,12% | FCF Growth (3Y) | 11,61% |
| Safety | |||
| Debt / Equity | 1,17 | Current Ratio | 4,29 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 28,96 | Forward P/E | 29,07 |
| P/B Ratio | 3,13 | P/S Ratio | 1,18 |
| PEG Ratio | -4,97 | Forward PEG | N/A |
| EV/EBITDA | 19,98 | Fwd EV/EBITDA | 13,05 |
| Forward P/S | 1,09 | Fwd Earnings Yield | 3,44% |
| FCF Yield | 5,20% | ||
| Market Cap | 33,57B | Enterprise Value | 44,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 28,43B | 25,51B | 23,23B | 21,45B |
| Net Income | 1,16B | 1,20B | 234,00M | -25,00M |
| EPS (Diluted) | 1,43 | 1,52 | 0,30 | -0,03 |
| Gross Profit | 7,52B | 6,29B | 5,22B | 4,56B |
| Operating Income | 2,21B | 2,23B | 1,44B | 870,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 38,48B | 35,98B | 36,12B |
| Total Liabilities | 19,20B | 19,45B | 19,15B |
| Shareholders' Equity | 10,74B | 16,52B | 16,98B |
| Total Debt | 12,56B | 16,90B | 16,83B |
| Cash & Equivalents | 1,94B | 250,00M | 1,59B |
| Current Assets | 10,68B | 8,27B | 8,81B |
| Current Liabilities | 2,49B | 2,44B | 2,13B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#695 of 1058
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026